Research

IN THIS SECTION 1. Overview 2. Research Focus 3. Projects 4. Publications

 

Publications

 

1992-1993

1993

Wallis JB, Supino P, Borer JS.  Prognostic value of left ventricular ejection fraction response to exercise during long-term follow-up after coronary bypass graft surgery. Circulation 1993;88[part 2]:99-109.

Borer JS. Atherosclerosis imaging: pathophysiological assessment for a new era. Journal of Nuclear Medicine 1993;34:1321-1325.

Hardoff R, Braegelmann F, Zanzonico P, Herrold EM, Lees RS, Lees AM, Dean R, Lister-James J, Borer JS.  External imaging of atherosclerosis in rabbits using an 123I-labeled synthetic peptide fragment. Journal of Clinical Pharmacology 1993;33:1039-1047.

Taylor HA, Chaitman BR, Rogers WJ, Kern MJ, Terrin ML, Aguirre FV, Sopko G, McMahon R, Ross RN, Bovill EC, TIMI Investigators (incl. Borer JS). Race and prognosis after myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial. Circulation 1993;88[part 1]:1484-1494.

Stein KM, Borer JS, Hochreiter C, Okin RM, Herrold EM, Devereux RB, Kligfield P. Prognostic value and physiological correlates of heart rate variability in chronic severe mitral regurgitation. Circulation 1993;88:127-135.

Magid NM, Borer JS, Young MS, Wallerson DC, De Monteiro C.  Suppression of protein degradation in progressive cardiac hypertrophy of chronic aortic regurgitation.  Circulation 1993;87:1249-1257.

Magid NM, Wallerson DC, Borer JS.  Myofibrillar protein turnover in cardiac hypertrophy due to aortic regurgitation.  Cardiology 1993;82:20-29.

1992

Herrold EM, Goldweit RS, Carter JN, Zuccotti G, Borer JS.  Non-invasive laser-based rabbit blood pressure measurement in rabbits.  American Journal of Hypertension 1992;5:197-202.

Magid NM, Wallerson DC, Borer JS, Mukherjee A, Young MS, Devereux RB, Carter JN. Left ventricular diastolic and systolic performance during chronic experimental aortic regurgitation.  American Journal of Physiology 1992;263(Heart Circ Physiol 32):H226-H233.

Zaret BL, Wackers FJTh, Terrin ML, Ross R, Weiss M, Slater J, Morrison J, Bourge RC, Passamani E, Knatterud G, and Braunwald E for the TIMI Investigators (incl. Borer JS).  Assessment of  global and regional left ventricular performance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) II study.  American Journal of Cardiology 1992;69:1-9.

Williams DO, Braunwald E, Knatterud G, Babb J, Bresnahan J, Greenberg MA, Raizner A, Wasserman A, Robertson T, Ross R, and TIMI Investigators (incl. Borer JS).  One-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial. Circulation 1992;85:533-542.

Mueller HS, Cohen LS, Braunwald E, Forman S, Feit F, Ross A, Schweiger M, Cabin H, Davison R, Miller D, Solomon R, Knatterud GL, for the TIMI Investigators (incl. Borer JS).  Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction: analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, Phase II. Circulation 1992;85:1254-1264.

Tofler GH, Muller JE, Stone PH, Forman S, Solomon RE, Knatterud GL, Braunwald E, and the TIMI Research Group (incl. Borer JS). Modifiers of timing and possible triggers  of acute myocardial infarcion in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group. Journal of the American College of Cardiology 1992; 20:1049-1055.

Kleiman NS, Terrin M, Mueller H, Chaitman B, Roberts R, Knatterud GL, Solomon R, McMahon RP, Braunwald, and the TIMI Investigators (incl. Borer JS). Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI
II) study. Journal of the American College of Cardiology 1992;19:1129-1135.

Barbut D, Borer JS, Gharavi A, Wallerson D, Devereux RB, Supino P, Suite N.  Prevalence of anticardiolipin antibody in isolated mitral or aortic regurgitation, or both, and possible relation to cerebral ischemic events.  American Journal of Cardiology 1992;70:901-905.

Borer JS. Atherogenesis and ischemia: two points on the pathophysiologic continuum, in Advances in Cardiovascular Pharmacology: Protocol Design and Methodology, Proceedings of the Eleventh Annual Symposium: Atherosclerosis and Drug Development for Ischemic Heart Disease, Borer JS, ed. Journal of Clinical Pharmacology 1992;32:848-866.

Borer JS. Drugs for atherosclerosis and for ischemia: have the indications for approval merged? in Advances in Cardiovascular Pharmacology (op cit 226). American Journal of Pharmacology 1992;32:849-852.

Carter JN, Herrold EM, Magid NM, Borer JS.  Computer automated non-invasive arterial pressure measurement II--microcontroller-based system.  Computers in Cardiology 1992;IEEE Publication #0276-6547/92:555-558.

Herrold EM, Carter JN, Borer JS.  Volume-overload-related shape change limits mass increase with wall thickening but only minimally reduces wall stress.  Computers in Cardiology, 1992;IEEE publication #0276-6547/92:287-290.

Stein KM, Borer JS, Hochreiter C, Kligfield P.  Fractal clustering of ventricular ectopy and sudden death in mitral regurgitation.  Journal of Electrocardiology, 1992;25:Supplement:178-181.

Magid NM, Opio G, King RK, Wallerson DC, Liu SK, Goldfine SM, Young MS, Borer JS.  Left ventricular hypertrophy and congestive heart failure in volume overload. Proceedings, Third International Symposium on the Pig Model for Biomedical Research (PRIT, Taipei), 1992:1-12.

 

< Prev

Next >